Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and their Families due to Uncomplicated and Hospitalised Varicella

Detalhes bibliográficos
Autor(a) principal: Rodrigues, F
Data de Publicação: 2023
Outros Autores: Marlow, R, Gouveia, C, Correia, P, Brett, A, Silva, C, Gameiro, I, Rua, I, Dias, J, Martins, M, Diogo, R, Lopes, T, Hipólito, E, Moreira, D, Costa Alves, M, Prata, F, Labrusco, M, Gomes, S, Fernandes, A, Andrade, A, Granjo Morais, C, João Virtuoso, M, Manuel Zarcos, M, Teresa Raposo, A, Boon, A, Finn, A
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/4522
Resumo: Introduction and aims: Although usually benign, varicella can lead to serious complications and sometimes long-term sequelae. Vaccines are safe and effective but not yet included in immunisation programmes in many countries. We aimed to quantify the impact on health-related quality of life (HRQoL) in terms of quality-adjusted life years (QALY) in children with varicella and their families, key to assessing cost-utility in countries with low mortality due to this infection. Methods: Children with varicella in the community and admitted to hospitals in Portugal were included over 18 months from January 2019. Children's and carers' HRQoL losses were assessed prospectively using standard multi-attribute utility instruments for measuring HRQoL (EQ-5D and CHU9D), from presentation to recovery, allowing the calculation of QALYs. Results: Among 109 families with children with varicella recruited from attendees at a pediatric emergency service (community arm), the mean HRQoL loss/child was 2.0 days (95 % CI 1.9-2.2, n = 101) (mean 5.4 QALYs/1000 children (95 % CI 5.3-6.1) and 1.3 days/primary carer (95 % CI 1.2-1.6, n = 103) (mean 3.6 QALYs /1000 carers (95 % CI 3.4-4.4). Among 114 families with children admitted to hospital because of severe varicella or a complication (hospital arm), the mean HRQoL loss/child was 9.8 days (95 % CI 9.4-10.6, n = 114) (mean 26.8 QALYs /1000 children (95 % CI 25.8-29.0) and 8.5 days/primary carer (95 % CI 7.4-9.6, n = 114) (mean 23.4 QALYs/1000 carers (95 % CI 20.3-26.2). Mean QALY losses/1000 patients were particularly high for bone and joint infections [67.5 (95 % CI 43.9-97.6)]. Estimates for children's QALYs lost using the CHU9D tool were well correlated with those obtained using EQ-5D, but substantially lower. Conclusions: The impact of varicella on HRQoL is substantial. We report the first measurements of QALYs lost in hospitalised children and in the families of children both in the community and admitted to hospital, providing important information to guide vaccination policy recommendations.
id RCAP_29f7df45b6efb1bb8d44ed1657bd7499
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/4522
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str
spelling Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and their Families due to Uncomplicated and Hospitalised VaricellaChickenpox* / epidemiologyChickenpox* / prevention & controlChildCost-Benefit AnalysisProspective StudiesPortugalQuality of Life*Quality-Adjusted Life YearsHDE INF PEDIntroduction and aims: Although usually benign, varicella can lead to serious complications and sometimes long-term sequelae. Vaccines are safe and effective but not yet included in immunisation programmes in many countries. We aimed to quantify the impact on health-related quality of life (HRQoL) in terms of quality-adjusted life years (QALY) in children with varicella and their families, key to assessing cost-utility in countries with low mortality due to this infection. Methods: Children with varicella in the community and admitted to hospitals in Portugal were included over 18 months from January 2019. Children's and carers' HRQoL losses were assessed prospectively using standard multi-attribute utility instruments for measuring HRQoL (EQ-5D and CHU9D), from presentation to recovery, allowing the calculation of QALYs. Results: Among 109 families with children with varicella recruited from attendees at a pediatric emergency service (community arm), the mean HRQoL loss/child was 2.0 days (95 % CI 1.9-2.2, n = 101) (mean 5.4 QALYs/1000 children (95 % CI 5.3-6.1) and 1.3 days/primary carer (95 % CI 1.2-1.6, n = 103) (mean 3.6 QALYs /1000 carers (95 % CI 3.4-4.4). Among 114 families with children admitted to hospital because of severe varicella or a complication (hospital arm), the mean HRQoL loss/child was 9.8 days (95 % CI 9.4-10.6, n = 114) (mean 26.8 QALYs /1000 children (95 % CI 25.8-29.0) and 8.5 days/primary carer (95 % CI 7.4-9.6, n = 114) (mean 23.4 QALYs/1000 carers (95 % CI 20.3-26.2). Mean QALY losses/1000 patients were particularly high for bone and joint infections [67.5 (95 % CI 43.9-97.6)]. Estimates for children's QALYs lost using the CHU9D tool were well correlated with those obtained using EQ-5D, but substantially lower. Conclusions: The impact of varicella on HRQoL is substantial. We report the first measurements of QALYs lost in hospitalised children and in the families of children both in the community and admitted to hospital, providing important information to guide vaccination policy recommendations.ElsevierRepositório do Centro Hospitalar Universitário de Lisboa Central, EPERodrigues, FMarlow, RGouveia, CCorreia, PBrett, ASilva, CGameiro, IRua, IDias, JMartins, MDiogo, RLopes, THipólito, EMoreira, DCosta Alves, MPrata, FLabrusco, MGomes, SFernandes, AAndrade, AGranjo Morais, CJoão Virtuoso, MManuel Zarcos, MTeresa Raposo, ABoon, AFinn, A2023-05-22T10:53:42Z20232023-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/4522engVaccine . 2023 Feb 3;41(6):1182-118910.1016/j.vaccine.2022.12.011info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-05-28T05:20:04ZPortal AgregadorONG
dc.title.none.fl_str_mv Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and their Families due to Uncomplicated and Hospitalised Varicella
title Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and their Families due to Uncomplicated and Hospitalised Varicella
spellingShingle Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and their Families due to Uncomplicated and Hospitalised Varicella
Rodrigues, F
Chickenpox* / epidemiology
Chickenpox* / prevention & control
Child
Cost-Benefit Analysis
Prospective Studies
Portugal
Quality of Life*
Quality-Adjusted Life Years
HDE INF PED
title_short Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and their Families due to Uncomplicated and Hospitalised Varicella
title_full Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and their Families due to Uncomplicated and Hospitalised Varicella
title_fullStr Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and their Families due to Uncomplicated and Hospitalised Varicella
title_full_unstemmed Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and their Families due to Uncomplicated and Hospitalised Varicella
title_sort Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and their Families due to Uncomplicated and Hospitalised Varicella
author Rodrigues, F
author_facet Rodrigues, F
Marlow, R
Gouveia, C
Correia, P
Brett, A
Silva, C
Gameiro, I
Rua, I
Dias, J
Martins, M
Diogo, R
Lopes, T
Hipólito, E
Moreira, D
Costa Alves, M
Prata, F
Labrusco, M
Gomes, S
Fernandes, A
Andrade, A
Granjo Morais, C
João Virtuoso, M
Manuel Zarcos, M
Teresa Raposo, A
Boon, A
Finn, A
author_role author
author2 Marlow, R
Gouveia, C
Correia, P
Brett, A
Silva, C
Gameiro, I
Rua, I
Dias, J
Martins, M
Diogo, R
Lopes, T
Hipólito, E
Moreira, D
Costa Alves, M
Prata, F
Labrusco, M
Gomes, S
Fernandes, A
Andrade, A
Granjo Morais, C
João Virtuoso, M
Manuel Zarcos, M
Teresa Raposo, A
Boon, A
Finn, A
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Rodrigues, F
Marlow, R
Gouveia, C
Correia, P
Brett, A
Silva, C
Gameiro, I
Rua, I
Dias, J
Martins, M
Diogo, R
Lopes, T
Hipólito, E
Moreira, D
Costa Alves, M
Prata, F
Labrusco, M
Gomes, S
Fernandes, A
Andrade, A
Granjo Morais, C
João Virtuoso, M
Manuel Zarcos, M
Teresa Raposo, A
Boon, A
Finn, A
dc.subject.por.fl_str_mv Chickenpox* / epidemiology
Chickenpox* / prevention & control
Child
Cost-Benefit Analysis
Prospective Studies
Portugal
Quality of Life*
Quality-Adjusted Life Years
HDE INF PED
topic Chickenpox* / epidemiology
Chickenpox* / prevention & control
Child
Cost-Benefit Analysis
Prospective Studies
Portugal
Quality of Life*
Quality-Adjusted Life Years
HDE INF PED
description Introduction and aims: Although usually benign, varicella can lead to serious complications and sometimes long-term sequelae. Vaccines are safe and effective but not yet included in immunisation programmes in many countries. We aimed to quantify the impact on health-related quality of life (HRQoL) in terms of quality-adjusted life years (QALY) in children with varicella and their families, key to assessing cost-utility in countries with low mortality due to this infection. Methods: Children with varicella in the community and admitted to hospitals in Portugal were included over 18 months from January 2019. Children's and carers' HRQoL losses were assessed prospectively using standard multi-attribute utility instruments for measuring HRQoL (EQ-5D and CHU9D), from presentation to recovery, allowing the calculation of QALYs. Results: Among 109 families with children with varicella recruited from attendees at a pediatric emergency service (community arm), the mean HRQoL loss/child was 2.0 days (95 % CI 1.9-2.2, n = 101) (mean 5.4 QALYs/1000 children (95 % CI 5.3-6.1) and 1.3 days/primary carer (95 % CI 1.2-1.6, n = 103) (mean 3.6 QALYs /1000 carers (95 % CI 3.4-4.4). Among 114 families with children admitted to hospital because of severe varicella or a complication (hospital arm), the mean HRQoL loss/child was 9.8 days (95 % CI 9.4-10.6, n = 114) (mean 26.8 QALYs /1000 children (95 % CI 25.8-29.0) and 8.5 days/primary carer (95 % CI 7.4-9.6, n = 114) (mean 23.4 QALYs/1000 carers (95 % CI 20.3-26.2). Mean QALY losses/1000 patients were particularly high for bone and joint infections [67.5 (95 % CI 43.9-97.6)]. Estimates for children's QALYs lost using the CHU9D tool were well correlated with those obtained using EQ-5D, but substantially lower. Conclusions: The impact of varicella on HRQoL is substantial. We report the first measurements of QALYs lost in hospitalised children and in the families of children both in the community and admitted to hospital, providing important information to guide vaccination policy recommendations.
publishDate 2023
dc.date.none.fl_str_mv 2023-05-22T10:53:42Z
2023
2023-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/4522
url http://hdl.handle.net/10400.17/4522
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Vaccine . 2023 Feb 3;41(6):1182-1189
10.1016/j.vaccine.2022.12.011
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1777302520183390208